Company profile BBIO
After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0. BridgeBio Pharma expected interest is significantly higher compared to previous quarter (+80.0%) and same quarter last year (+67.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 63 | 41 -34.9% QoQ | 51 24.4% QoQ | 46 -9.8% QoQ |
| 2020 | 10 -84.1% YoY -78.3% QoQ | 33 -19.5% YoY 230.0% QoQ | 41 -19.6% YoY 24.2% QoQ | 12 -73.9% YoY -70.7% QoQ |
| 2021 | 86 760.0% YoY 616.7% QoQ | 69 109.1% YoY -19.8% QoQ | 13 -68.3% YoY -81.2% QoQ | 128 966.7% YoY 884.6% QoQ |
| 2022 | 142 65.1% YoY 10.9% QoQ | 51 -26.1% YoY -64.1% QoQ | 50 284.6% YoY -2.0% QoQ | 48 -62.5% YoY -4.0% QoQ |
| 2023 | 43 -69.7% YoY -10.4% QoQ | 43 -15.7% YoY 0.0% QoQ | 92 84.0% YoY 114.0% QoQ | 40 -16.7% YoY -56.5% QoQ |
| 2024 | 31 -27.9% YoY -22.5% QoQ | - | - | - |
The average 5 years interest of BridgeBio Pharma was 4.34 per week. The last year interest of BridgeBio Pharma compared to the last 5 years has changed by 3.23%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 15.76%.
There is not enough data for BridgeBio Pharma medicines to provide analysis
There is not enough data for BridgeBio Pharma medicines to provide correlation calculation
There is not enough data for BridgeBio Pharma medicines to provide analysis
There is not enough data for BridgeBio Pharma rare diseases to provide analysis
There is not enough data for BridgeBio Pharma rare diseases to provide correlation calculation
There is not enough data for BridgeBio Pharma rare diseases to provide analysis
There is not enough data for BridgeBio Pharma TTR amyloidosis to provide analysis
There is not enough data for BridgeBio Pharma TTR amyloidosis to provide correlation calculation
There is not enough data for BridgeBio Pharma TTR amyloidosis to provide analysis
There is not enough data for BridgeBio Pharma achondroplasia to provide analysis
There is not enough data for BridgeBio Pharma achondroplasia to provide correlation calculation
There is not enough data for BridgeBio Pharma achondroplasia to provide analysis
There is not enough data for BridgeBio Pharma gene therapy to provide analysis
There is not enough data for BridgeBio Pharma gene therapy to provide correlation calculation
There is not enough data for BridgeBio Pharma gene therapy to provide analysis
There is not enough data for BridgeBio Pharma clinical trials to provide analysis
There is not enough data for BridgeBio Pharma clinical trials to provide correlation calculation
There is not enough data for BridgeBio Pharma clinical trials to provide analysis
After 39 days of this quarter the interest is at 49.0. Based on that we can calculate that during remaining 52 days it will total up to 114.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 49 | 49 0.0% QoQ | 109 122.4% QoQ | 79 -27.5% QoQ |
| 2020 | 105 114.3% YoY 32.9% QoQ | 176 259.2% YoY 67.6% QoQ | 66 -39.4% YoY -62.5% QoQ | 90 13.9% YoY 36.4% QoQ |
| 2021 | 134 27.6% YoY 48.9% QoQ | 191 8.5% YoY 42.5% QoQ | 21 -68.2% YoY -89.0% QoQ | 197 118.9% YoY 838.1% QoQ |
| 2022 | 128 -4.5% YoY -35.0% QoQ | 33 -82.7% YoY -74.2% QoQ | 129 514.3% YoY 290.9% QoQ | 61 -69.0% YoY -52.7% QoQ |
| 2023 | 140 9.4% YoY 129.5% QoQ | 100 203.0% YoY -28.6% QoQ | 96 -25.6% YoY -4.0% QoQ | 93 52.5% YoY -3.1% QoQ |
| 2024 | 49 -65.0% YoY -47.3% QoQ | - | - | - |
The average 5 years interest of BridgeBio Pharma stock was 8.03 per week. The last year interest of BridgeBio Pharma stock compared to the last 5 years has changed by 8.97%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 29.63%.
There is not enough data for BridgeBio Pharma careers to provide analysis
There is not enough data for BridgeBio Pharma careers to provide correlation calculation
There is not enough data for BridgeBio Pharma careers to provide analysis
After 39 days of this quarter the interest is at 58.0. Based on that we can calculate that during remaining 52 days it will total up to 135.0. BridgeBio Pharma -stock -company expected interest is significantly higher compared to same quarter last year (+264.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 59 inf% QoQ | 122 106.8% QoQ | 75 -38.5% QoQ |
| 2020 | 69 inf% YoY -8.0% QoQ | 16 -72.9% YoY -76.8% QoQ | 77 -36.9% YoY 381.2% QoQ | 19 -74.7% YoY -75.3% QoQ |
| 2021 | 92 33.3% YoY 384.2% QoQ | 56 250.0% YoY -39.1% QoQ | 0 -100.0% YoY -100.0% QoQ | 214 1026.3% YoY inf% QoQ |
| 2022 | 74 -19.6% YoY -65.4% QoQ | 128 128.6% YoY 73.0% QoQ | 45 inf% YoY -64.8% QoQ | 106 -50.5% YoY 135.6% QoQ |
| 2023 | 37 -50.0% YoY -65.1% QoQ | 31 -75.8% YoY -16.2% QoQ | 137 204.4% YoY 341.9% QoQ | 106 0.0% YoY -22.6% QoQ |
| 2024 | 58 56.8% YoY -45.3% QoQ | - | - | - |
The average 5 years interest of BridgeBio Pharma -stock -company was 5.83 per week. The last year interest of BridgeBio Pharma -stock -company compared to the last 5 years has changed by 16.47%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 26.44%.